ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study.

Matthew G Krebs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.